HIND Vyome Holdings, Inc.

2.040USD-0.97%Mkt Cap: 14.32M $P/E: 1.15

Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechn…

Key Statistics

Company
Market Cap14.32M USD
Enterprise Value7.85M USD
Revenue (TTM)129.72K USD
Gross Profit218.77K USD
Net Income (TTM)-10.26M USD
Revenue/Share0.02 USD
Last Price2.040 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees9
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)1.15
P/E (Forward)—
PEG—
EV/EBITDA-1.87
EV/Revenue60.52
P/S111.45
P/B2.39
EPS (TTM)1.87
EPS (Forward)—
52W Range
1.7506% of range6.560
52W High6.560 USD
52W Low1.750 USD
Profitability
Gross Margin68.43%
Oper. Margin-3200.02%
EBITDA Margin0.00%
Profit Margin-3209.75%
ROE-420.22%
ROA-157.95%
Growth
Revenue Growth-46.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.75M USD
CapEx (TTM)—
FCF Margin2807.21%
FCF Yield25.43%
Net Debt-7.87M USD
Net Debt/EBITDA1.87
Balance Sheet
Debt/Equity0.01
Current Ratio4.37
Quick Ratio4.31
Book Value/Sh0.86 USD
Cash/Share1.12 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateAug 15, 2025
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.833 USD
Upside (mean)+333.0%
Target Range3.500 USD – 15.00 USD
3.500+333.0% to mean15.00
# Analysts3
Ownership
Shares Out.7.02M
Float3.65M
Insiders52.88%
Institutions2.18%
Short Interest
Short Ratio2.6d
Short % Float0.48%
Short % Out.0.31%
Shares Short21.51K
Short (prev mo.)24.52K
Technical
SMA 502.108 (-3.2%)
SMA 2002.398 (-14.9%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)17.41K
Avg Vol (10d)10.57K
Technical Indicators
RSI (14)49.5
MACD-0.0402
MACD Signal-0.0459
MACD Hist.+0.0057
BB Upper2.143 USD
BB Middle2.015 USD
BB Lower1.888 USD
BB Width12.69%
ATR (14)0.0984 USD
Vol Ratio (20d)0.53x